Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies

A. Blauvelt, C. Paul, P. van de Kerkhof, R. B. Warren, A. B. Gottlieb, R. G. Langley, F. Brock, C. Arendt, M. Boehnlein, M. Lebwohl, K. Reich

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science